Rexahn Pharmaceuticals Announces Clinical Collaboration with Merck to Evaluate RX-5902 (Supinoxin™) in ...
Under the terms of the agreement, Rexahn will sponsor the RX-5902 and KEYTRUDA study. KEYTRUDA® is a registered trademark of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. About RX-5902. RX-5902 (Supinoxin) ...
How Merck solved its clinical data challenges
Data collection has never been easier, but data control presents a new challenge for businesses. A map is essential to make full use of the information - and comply with GDPR - but too much data turns this important tool into a bottleneck. That was the ...
Unicom Global buys former Merck property
The former Merck & Co. campus finally has a buyer. UNICOM Corp., a division of UNICOM Global, announced Thursday it has signed an agreement with Merck Sharpe & Dohme Corp. to purchase the Merck property at Whitehouse Station in the Township of ...